azelastine and etretinate

azelastine has been researched along with etretinate in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Bolsmann, K; Braam, U; Eichelberg, D; Greven, T; Jungbluth, C; Schmutzler, W; Zwadlo-Klarwasser, G	1

Other Studies

2 other study(ies) available for azelastine and etretinate

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Histamine release from mast cells and monocytes: the effects of azelastine, reproterol and vitamin A-analogues. Inflammation research : official journal of the European Histamine Research Society ... [et al.], 1996, Volume: 45 Suppl 1 Topics: Adrenergic beta-Agonists; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; beta Carotene; Carotenoids; Dose-Response Relationship, Drug; Drug Combinations; Etretinate; Histamine H1 Antagonists; Histamine Release; Humans; Isotretinoin; Keratolytic Agents; Mast Cells; Metaproterenol; Monocytes; Phthalazines; Quinolines; Superoxide Dismutase; Theophylline	1996

Article

Year

Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.

Current drug discovery technologies, 2004, Volume: 1, Issue:4

Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004

Histamine release from mast cells and monocytes: the effects of azelastine, reproterol and vitamin A-analogues.

Inflammation research : official journal of the European Histamine Research Society ... [et al.], 1996, Volume: 45 Suppl 1

Topics: Adrenergic beta-Agonists; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; beta Carotene; Carotenoids; Dose-Response Relationship, Drug; Drug Combinations; Etretinate; Histamine H1 Antagonists; Histamine Release; Humans; Isotretinoin; Keratolytic Agents; Mast Cells; Metaproterenol; Monocytes; Phthalazines; Quinolines; Superoxide Dismutase; Theophylline

1996